Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13355)
All Articles published online
|
Publishing Process of This Article
|
Sep 20, 2024 (publication date) through Feb 26, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Experimental Medicine
ISSN
2220-315x
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Kokudeva M, Vichev M, Naseva E, Miteva DG, Velikova T. Artificial intelligence as a tool in drug discovery and development. World J Exp Med 2024; 14(3): 96042 [PMID: 39312699 DOI: 10.5493/wjem.v14.i3.96042] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Kokudeva M, Vichev M, Naseva E, Miteva DG, Velikova T. Artificial intelligence as a tool in drug discovery and development. World J Exp Med 2024; 14(3): 96042 [PMID: 39312699 DOI: 10.5493/wjem.v14.i3.96042] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315x/full/v14/i3/96042.htm |
| Number | Citing Articles |
| 1 |
Bakr Ahmed Taha, Ali J. Addie, Luai Farhan Zghair Kolie, Saba Talib Wahhab, Sinan Adnan Abdulateef, Adawiya J. Haider, Khalid Ibnaouf, Norhana Arsad. Advancements in nanophotonics and smart nanomaterials integrated with artificial intelligence-driven gene editing: A paradigm shift in cancer diagnosis and therapeutic. Chinese Chemical Letters 2026; 37(4): 111955 doi: 10.1016/j.cclet.2025.111955
|
| 2 |
Razvan Onciul, Catalina-Ioana Tataru, Adrian Vasile Dumitru, Carla Crivoi, Matei Serban, Razvan-Adrian Covache-Busuioc, Mugurel Petrinel Radoi, Corneliu Toader. Artificial Intelligence and Neuroscience: Transformative Synergies in Brain Research and Clinical Applications. Journal of Clinical Medicine 2025; 14(2): 550 doi: 10.3390/jcm14020550
|
| 3 |
Elisa Avolio, Barbara Bassani, Marzia Campanile, Khaled AK. Mohammed, Paola Muti, Antonino Bruno, Gaia Spinetti, Paolo Madeddu. Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing?. Pharmacological Reviews 2025; 77(2): 100033 doi: 10.1016/j.pharmr.2024.100033
|
| 4 |
Artificial intelligence in drug discovery and development: transforming challenges into opportunities. Discover Pharmaceutical Sciences 2025; 1(1) doi: 10.1007/s44395-025-00007-3
|
| 5 |
M. Dimitrova, R. Trifonova, G. Stavrakov, I. Doytchinova, G. Petrova. Artificial Intelligence-Based Approaches for Improving Regulatory Market Access – A Case Study with A Scoping Review for Repurposing of Medicinal Products in the Pandemic. Acta Medica Bulgarica 2026; 53(s1): 155 doi: 10.2478/amb-2026-0026
|
| 6 |
Aliasgar Baldiwala, Azim M Baldiwala, Manan Patel, Pritkumar Amrutiya, Gopal Natesan, Udit Chaube. Artificial intelligence for next-generation anxiolytic drug discovery: current trends, challenges, and future perspectives. Chemical Papers 2026; doi: 10.1007/s11696-025-04598-0
|
| 7 |
Alaa Marwan-Abu-Taha. Elevating Research and Careers in the Development of Safer Drugs through Artificial Intelligence. Chemical Research in Toxicology 2025; 38(3): 365 doi: 10.1021/acs.chemrestox.4c00423
|
| 8 |
Amauri Duarte da Silva, Walter Filgueira de Azevedo. Docking Screens for Drug Discovery. Methods in Molecular Biology 2026; 2984: 65 doi: 10.1007/978-1-0716-4949-7_5
|
| 9 |
Ádám Pannonhalmi, Bence Sipos, Róbert Imre Kurucz, Gábor Katona, Lajos Kemény, Ildikó Csóka. Advancing Regulatory Oversight of Medical Device Trials to Align with Clinical Drug Standards in the European Union. Pharmaceuticals 2025; 18(6): 876 doi: 10.3390/ph18060876
|
| 10 |
Bruno F. E. Matarèse. Quantum and Artificial Intelligence in Drugs and Pharmaceutics. BioChem 2026; 6(1): 2 doi: 10.3390/biochem6010002
|
| 11 |
Sanjit Kr. Roy, Kazi Asraf Ali, Subhankar Saha, Bichitra Biswas. Revolutionizing Drug Development. 2026; : 243 doi: 10.1016/B978-0-443-34059-8.00014-2
|
| 12 |
Shahrzad Latifi. Targeting Brain Networks for Recovery: Multimodal Innovations in Poststroke Therapy. Stroke 2026; doi: 10.1161/STROKEAHA.125.053926
|
| 13 |
Sara Laianny Ferreira Cunha, Maria de Jesus Costa das Neves , Franciélio Alves Silva , Raynara Beatriz Magalhães Morais , Luiza Sousa Oliveira , Beatriz Lisboa Pinto , Letícia Alves Santos , Kalynna Beatriz Araujo Diniz , Kamila Cristhine Bede Camilo , Karen Silva de Almeida . AVANÇOS NO DIAGNÓSTICO E TRATAMENTO DE DOENÇAS NEUROLÓGICAS: NOVAS ESTRATÉGIAS TERAPÊUTICAS E DESAFIOS CLÍNICOS NO CONTEXTO ATUAL. Cognitus Interdisciplinary Journal 2025; 2(2): 353 doi: 10.71248/xmdf9133
|
| 14 |
Mohammad Javad Mehran, Sara Mohammadzadeh, Mansoor Bolideei, Rambod Barzigar, Khawaja Husnain Haider, Nasir Jadgal, Yadollah Bahrami. Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic Innovation. Drug Development Research 2026; 87(2) doi: 10.1002/ddr.70229
|
| 15 |
Somayah J. Jarallah, Fahad A. Almughem, Nada K. Alhumaid, Nojoud AL Fayez, Ibrahim Alradwan, Khulud A. Alsulami, Essam A. Tawfik, Abdullah A. Alshehri. Artificial intelligence revolution in drug discovery: A paradigm shift in pharmaceutical innovation. International Journal of Pharmaceutics 2025; 680: 125789 doi: 10.1016/j.ijpharm.2025.125789
|
| 16 |
K. Daqrouq, S. Alghamedi, S. Alwaseli, A. F. Alkhateeb, Sami Alghamdi, M. N. Ajour, A. S. Balamash, A. Milyani, K. Alharbi, A. M. Rushdi, Giovanni Angiulli. Impact of the Utilization of Artificial Intelligence in the Development of Electrical Engineering. Journal of Engineering 2025; 2025(1) doi: 10.1155/je/1390935
|
| 17 |
Surendra Prakash Gupta, Ankur Bhardwaj. AI and Ecological Change for Sustainable Development. Advances in Computational Intelligence and Robotics 2025; : 415 doi: 10.4018/979-8-3373-0680-3.ch014
|
| 18 |
Vinay Kumar, Kunal Roy. Embracing the changes and challenges with modern early drug discovery. Expert Opinion on Drug Discovery 2025; 20(4): 419 doi: 10.1080/17460441.2025.2481259
|
| 19 |
AI-driven approaches in therapeutic interventions: Transforming RNA-seq analysis into biomarker discovery and drug development. Drug Discovery Today 2025; 30(7): 104391 doi: 10.1016/j.drudis.2025.104391
|
| 20 |
Mikhail Parshenkov, Sergey Zyryanov, Galina Rodionova, Anna Dyakonova, Petr Shegay, Andrei Kaprin, Grigory Demyashkin. Personalizing Antidepressant Therapy: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Digital Tools for Improved Depression Outcomes. Journal of Personalized Medicine 2025; 15(12): 616 doi: 10.3390/jpm15120616
|
| 21 |
Kathirvel Sekar, Kaviyarasi Renu, Sathishkumar Vinayagam, Devianjana Rajendran, Kamaraj Sattu. In Silico Development of PABA-substituted Pyrimidine Derivatives Targeting Mutant p53 for Precision Therapy in Oral Squamous Cell Carcinoma. Journal of Advanced Oral Research 2025; 16(2): 241 doi: 10.1177/23202068251330106
|
| 22 |
Sonopant Joshi, Husain Nadaf, Mangesh Jabade, Shital Pimpalekar. Artificial Intelligence in Oncology. 2025; : 595 doi: 10.1007/978-3-031-94302-7_42
|
| 23 |
Pankaj Garg, Gargi Singhal, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal. Artificial Intelligence–Driven Computational Approaches in the Development of Anticancer Drugs. Cancers 2024; 16(22): 3884 doi: 10.3390/cancers16223884
|
| 24 |
Raja Ahmed, Suraiya Akhtar, Ankur Das, Khaleda Begum, Abhijit Sarma, Amartya Chakraborty, Tanisha Neog, Sofia Banu. Revolutionizing Drug Development. 2026; : 293 doi: 10.1016/B978-0-443-34059-8.00010-5
|
| 25 |
Da Li, Sanbao Shi, Zhiyu Yu, Peng Xu, Cheng Zhang. AI accelerate the identification of druggable targets by 3D structures of proteins and compounds. npj Precision Oncology 2026; doi: 10.1038/s41698-026-01310-7
|
| 26 |
Hema Brindha Masanam, Siva Prasath Ramasamy, Sapthagirivasan Vivekanandhan, Ashwin Kumar Narasimhan. Precision Medicine Demanding Artificial Intelligence for Nanodrug Delivery Enhancing Cancer Treatment. Nano LIFE 2026; 16(04) doi: 10.1142/S1793984425300079
|